Cargando…
Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson’s Disease
Background: Parkinson’s disease (PD) is the second most common age-related neurodegenerative disorder. Levodopa (L-DOPA) remains the gold-standard drug available for treating PD. Curcumin has many pharmacological activities, including antioxidant, anti-inflammatory, antimicrobial, anti-amyloid, and...
Autores principales: | Mogharbel, Bassam Felipe, Cardoso, Marco André, Irioda, Ana Carolina, Stricker, Priscila Elias Ferreira, Slompo, Robson Camilotti, Appel, Julia Maurer, de Oliveira, Nathalia Barth, Perussolo, Maiara Carolina, Saçaki, Claudia Sayuri, da Rosa, Nadia Nascimento, Dziedzic, Dilcele Silva Moreira, Travelet, Christophe, Halila, Sami, Borsali, Redouane, de Carvalho, Katherine Athayde Teixeira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101601/ https://www.ncbi.nlm.nih.gov/pubmed/35566173 http://dx.doi.org/10.3390/molecules27092811 |
Ejemplares similares
-
State of the Art of microRNAs Signatures as Biomarkers and Therapeutic Targets in Parkinson’s and Alzheimer’s Diseases: A Systematic Review and Meta-Analysis
por: Zotarelli-Filho, Idiberto José, et al.
Publicado: (2023) -
Adipose-Derived Stromal Cells and Mineralized Extracellular Matrix Delivery by a Human Decellularized Amniotic Membrane in Periodontal Tissue Engineering
por: Dziedzic, Dilcele Silva Moreira, et al.
Publicado: (2021) -
Demyelination Lesions Do Not Correlate with Clinical Manifestations by Bordetella pertussis Toxin Concentrations
por: Perussolo, Maiara Carolina, et al.
Publicado: (2022) -
Natural Membrane Differentiates Human Adipose-Derived Mesenchymal Stem Cells to Neurospheres by Mechanotransduction Related to YAP and AMOT Proteins
por: de Oliveira, Nathalia Barth, et al.
Publicado: (2021) -
Three-Dimensional Bioprinting of an In Vitro Lung Model
por: da Rosa, Nádia Nascimento, et al.
Publicado: (2023)